4.4 Article

Fibromyalgia and neuropathic pain - differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia

Journal

BMC NEUROLOGY
Volume 11, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/1471-2377-11-55

Keywords

-

Funding

  1. Pfizer Deutschland GmbH, Germany
  2. Pfizer Ltd., Europe
  3. Grunenthal
  4. Lilly/Boehringer
  5. Astellas
  6. Pfizer Pharma
  7. UCB/Schwarz Pharma
  8. Mundipharma
  9. Allergan
  10. Genzyme
  11. Sanofi Pasteur
  12. Medtronic
  13. Eisai
  14. Hexal
  15. Janssen-Cilag
  16. Lilly/Boehringe
  17. UCB/Schwarz

Ask authors/readers for more resources

Background: Patients with diabetic neuropathy (DPN) and fibromyalgia differ substantially in pathogenetic factors and the spatial distribution of the perceived pain. We questioned whether, despite these obvious differences, similar abnormal sensory complaints and pain qualities exist in both entities. We hypothesized that similar sensory symptoms might be associated with similar mechanisms of pain generation. The aims were (1) to compare epidemiological features and co-morbidities and (2) to identify similarities and differences of sensory symptoms in both entities. Methods: The present multi-center study compares epidemiological data and sensory symptoms of a large cohort of 1434 fibromyalgia patients and 1623 patients with painful diabetic neuropathy. Data acquisition included standard demographic questions and self-report questionnaires (MOS sleep scale, PHQ-9, PainDETECT). To identify subgroups of patients with characteristic combinations of symptoms (sensory profiles) a cluster analysis was performed using all patients in both cohorts. Results: Significant differences in co-morbidities (depression, sleep disturbance) were found between both disorders. Patients of both aetiologies chose very similar descriptors to characterize their sensory perceptions. Burning pain, prickling and touch-evoked allodynia were present in the same frequency. Five subgroups with distinct symptom profiles could be detected. Two of the subgroups were characteristic for fibromyalgia whereas one profile occurred predominantly in DPN patients. Two profiles were found frequently in patients of both entities (20-35%). Conclusions: DPN and fibromyalgia patients experience very similar sensory phenomena. The combination of sensory symptoms - the sensory profile - is in most cases distinct and almost unique for each one of the two entities indicating aetiology-specific mechanisms of symptom generation. Beside the unique aetiology-specific sensory profiles an overlap of sensory profiles can be found in 20-35% of patients of both aetiologies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

A retrospective analysis of the long-term test-retest stability of pain descriptors of the painDETECT questionnaire

T. Keller, R. Freynhagen, T. R. Toelle, I. Liwowsky, P. Moeller, P. Huellemann, U. Gockel, E. Stemmler, R. Baron

CURRENT MEDICAL RESEARCH AND OPINION (2016)

Article Anesthesiology

Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?

P. Marchettini, S. Wilhelm, H. Petto, S. Tesfaye, T. Toelle, D. Bouhassira, R. Freynhagen, G. Cruccu, A. Lledo, E. Choy, E. Kosek, J. A. Mico, M. Spaeth, V. Skljarevski, A. Lenox-Smith, S. Perrot

EUROPEAN JOURNAL OF PAIN (2016)

Review Clinical Neurology

Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review

Rainer Freynhagen, Miroslav Backonja, Stephan Schug, Gavin Lyndon, Bruce Parsons, Stephen Watt, Regina Behar

CNS DRUGS (2016)

Article Genetics & Heredity

Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses

D. Kringel, A. Ultsch, M. Zimmermann, J-P Jansen, W. Ilias, R. Freynhagen, N. Griessinger, A. Kopf, C. Stein, A. Doehring, E. Resch, J. Loetsch

PHARMACOGENOMICS JOURNAL (2017)

Article Anesthesiology

Pain Drawings Improve Subgrouping of Low Back Pain Patients

Philipp Huellemann, Thomas Keller, Maria Kabelitz, Rainer Freynhagen, Thomas Toelle, Ralf Baron

PAIN PRACTICE (2017)

Article Anesthesiology

Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles

Ralf Baron, Christoph Maier, Nadine Attal, Andreas Binder, Didier Bouhassira, Giorgio Cruccu, Nanna B. Finnerup, Maija Haanpaa, Per Hansson, Philipp Huellemann, Troels S. Jensen, Rainer Freynhagen, Jeffrey D. Kennedy, Walter Magerl, Tina Mainka, Maren Reimer, Andrew S. C. Rice, Marta Segerdahl, Jordi Serra, Soren Sindrup, Claudia Sommer, Thomas Toelle, Jan Vollert, Rolf-Detlef Treede

Article Anesthesiology

Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial

Annette Christoph, Marie-Henriette Eerdekens, Maurits Kok, Gisela Volkers, Rainer Freynhagen

Article Anesthesiology

Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations

Jan Vollert, Christoph Maier, Nadine Attal, David L. H. Bennett, Didier Bouhassira, Elena K. Enax-Krumova, Nanna B. Finnerup, Rainer Freynhagen, Janne Gierthmuehlen, Maija Haanpaa, Per Hansson, Philipp Hullemann, Troels S. Jensen, Walter Magerl, Juan D. Ramirez, Andrew S. C. Rice, Sigrid Schuh-Hofer, Marta Segerdahl, Jordi Serra, Pallai R. Shillo, Soeren Sindrup, Solomon Tesfaye, Andreas C. Themistocleous, Thomas R. Toelle, Rolf-Detlef Treede, Ralf j Baron

Review Medicine, General & Internal

Safety of tapentadol compared with other opioids in chronic pain treatment: network meta-analysis of randomized controlled and withdrawal trials

R. Freynhagen, C. Elling, T. Radic, M. Sohns, H. Liedgens, D. James, R. McCool, M. Edwards

Summary: This study aimed to assess the relative safety of oral tapentadol PR and other opioid analgesics for moderate or severe chronic pain in adults through a systematic review and network meta-analysis. The evidence from RCTs suggested that tapentadol is associated with relatively lower odds of adverse events compared to most active comparators. However, the data from withdrawal trials were less clear with higher uncertainty around the results and appeared to contradict the RCT evidence.

CURRENT MEDICAL RESEARCH AND OPINION (2021)

Article Medicine, General & Internal

When to consider mixed pain? The right questions can make a difference!

Rainer Freynhagen, Roberto Rey, Charles Argoff

CURRENT MEDICAL RESEARCH AND OPINION (2020)

Article Medicine, General & Internal

Cross-cultural adaptation and validation of the Persian version of the painDETECT questionnaire

Leila Ghamkhar, S. Mohaddesseh Saghaeian, Hoda Niknam, Seyed-Masoud Hashemi, Rainer Freynhagen, Amir H. Kahlaee

Summary: The objective of this study was to translate and adapt the painDETECT questionnaire into Persian, resulting in the reliable Persian version P-PDQ. The P-PDQ showed good internal consistency, test-retest reliability, and significant correlation with validated measures, making it a valuable tool in identifying neuropathic components in chronic pain cases.

CURRENT MEDICAL RESEARCH AND OPINION (2021)

Article Anesthesiology

Cross-cultural adaptation of the painDETECT questionnaire into Brazilian Portuguese

Jessica Pinto Martins do Rio, Juliana Valentim Bittencourt, Leticia Amaral Correa, Rainer Freynhagen, Felipe Jose Jandre dos Reis, Tamiris Barbosa de Melo, Diego Galace, Leandro Alberto Calazans Nogueira

Summary: The study translated and cross-culturally adapted the painDETECT questionnaire into Brazilian Portuguese, with good internal consistency for identifying neuropathic components in pain among Brazilian patients.

BRAZILIAN JOURNAL OF ANESTHESIOLOGY (2022)

Article Anesthesiology

Association of sensory phenotype with quality of life, functionality, and emotional well-being in patients suffering from neuropathic pain

Janne Gierthmuehlen, Johann Boehmer, Nadine Attal, Didier Bouhassira, Rainer Freynhagen, Maija Haanpaa, Per Hansson, Troels Staehelin Jensen, Jeffrey Kennedy, Christoph Maier, Andrew S. C. Rice, Juliane Sachau, Marta Segerdahl, Soren Sindrup, Thomas Toelle, Rolf-Detlef Treede, Lise Ventzel, Jan Vollert, Ralf Baron

Summary: Neuropathic pain patients can be categorized into sensory loss, mechanical hyperalgesia, and thermal hyperalgesia phenotypes, which have different impacts on mental health, functionality, and quality of life. Sensory loss patients experience higher pain interference, lower self-reported health state, and more problems with mobility, usual activities, and self-care compared to thermal hyperalgesia patients. These results suggest that the somatosensory phenotype should be considered for personalized pain management.
Article Medicine, General & Internal

Treatment of painful radiculopathies with capsaicin 8% cutaneous patch

R. Baron, R. D. Treede, F. Birklein, T. Cegla, R. Freynhagen, M. L. Heskamp, K. U. Kern, C. Maier, R. Rolke, S. Seddigh, C. Sommer, S. Staender, C. Maihoefner

CURRENT MEDICAL RESEARCH AND OPINION (2017)

Review Anesthesiology

Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles

M. R. Mulvey, E. G. Boland, D. Bouhassira, R. Freynhagen, J. Hardy, M. J. Hjermstad, S. Mercadante, C. Perez, M. I. Bennett

BRITISH JOURNAL OF ANAESTHESIA (2017)

No Data Available